Atea Pharmaceuticals Inc
NASDAQ:AVIR 12:36:13 PM EDT
| Market Cap (Intraday) | 2.06B |
| Current PE | 86.59 |
| Forward PE | 28.91 |
| 2yr Forward PE | 2.06 |
| 10-Day MA | $24.69 |
| 50-Day MA | $23.16 |
| 200-Day MA | N/A |
Atea Pharmaceuticals Inc Stock, NASDAQ:AVIR
125 Summer Street, Boston, Massachusetts 02110
United States of America
Phone: +1.857.284.8891
Number of Employees: 39
Description
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.